Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zoetis ( (ZTS) ) has shared an announcement.
On October 9, 2025, Zoetis announced a dividend of $0.50 per share for the fourth quarter of 2025, to be paid on December 2, 2025, to shareholders of record as of October 31, 2025. This decision reflects Zoetis’s ongoing commitment to returning value to its shareholders and may influence market perceptions of the company’s financial health and stability.
The most recent analyst rating on (ZTS) stock is a Buy with a $173.00 price target. To see the full list of analyst forecasts on Zoetis stock, see the ZTS Stock Forecast page.
Spark’s Take on ZTS Stock
According to Spark, TipRanks’ AI Analyst, ZTS is a Outperform.
Zoetis’ strong financial performance and positive earnings call are the primary drivers of its overall score. The company’s robust profitability, improved balance sheet, and raised guidance underscore its growth potential. However, the neutral technical indicators and moderate valuation suggest a balanced risk-reward profile.
To see Spark’s full report on ZTS stock, click here.
More about Zoetis
Zoetis is the world’s leading animal health company, dedicated to advancing care for animals by providing a portfolio of medicines, vaccines, diagnostics, and technologies. With over 70 years of innovation, Zoetis supports veterinarians, pet owners, and livestock producers in more than 100 countries. The company, a Fortune 500 entity, reported $9.3 billion in revenue in 2024 and employs approximately 13,800 people.
Average Trading Volume: 3,087,933
Technical Sentiment Signal: Sell
Current Market Cap: $63.27B
For detailed information about ZTS stock, go to TipRanks’ Stock Analysis page.